Mirari Echepare

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

DSTYK Inhibition Sensitizes NSCLC to Taxane-Based Chemotherapy.

YES1 Is a Druggable Oncogenic Target in SCLC.

Showing 1-10 of 10

Last Updated: 09/26/2026